日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

在非人灵长类动物中,通过玻璃体内基因治疗候选药物 ADVM-022 持续眼内递送阿柏西普的长期安全性评估

Kiss, Szilárd; Oresic Bender, Kristina; Grishanin, Ruslan N; Hanna, Kelly M; Nieves, Julio D; Sharma, Pallavi; Nguyen, Aivan T; Rosario, Romeo J; Greengard, Judith S; Gelfman, Claire M; Gasmi, Mehdi

Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.

对非人灵长类动物玻璃体内注射 ADVM-022(一种潜在的 nAMD 基因疗法)后 Aflibercept 表达的分析

Kiss Szilárd, Grishanin Ruslan, Nguyen Aivan, Rosario Romeo, Greengard Judith S, Nieves Julio, Gelfman Claire M, Gasmi Mehdi